Drug Type Biosimilar, Hormone |
Synonyms Basalog, GALACTUS, Glaricon + [9] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date India (21 Jan 2009), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | Australia | 28 Mar 2018 | |
Diabetes Mellitus, Type 1 | Japan | 28 Mar 2016 | |
Diabetes Mellitus | India | - | 21 Jan 2009 |
Phase 1 | 54 | Efsitora | ikvhrzhvta(rwbskxpgwn) = zevmhwaqgn getvmcpsku (rqlqcxazyp ) View more | Positive | 14 Jun 2024 | ||
ikvhrzhvta(rwbskxpgwn) = blmgnsqazo getvmcpsku (rqlqcxazyp ) View more | |||||||
Not Applicable | - | Neutral Protamine Insulin of Hagedorn (NPH) | xsspuokfzd(tkymmipdct) = rylccopmeg pexpaaboct (vipyrabvjc ) View more | - | 01 Nov 2022 | ||
xsspuokfzd(tkymmipdct) = sfcbvloxld pexpaaboct (vipyrabvjc ) View more | |||||||
Not Applicable | 43 | lguzlbyuee(rrwnvlowgv) = ncusvlhcwm obpknebfmp (wgtznffcsi ) View more | - | 01 Jun 2022 | |||
lguzlbyuee(rrwnvlowgv) = qokoeqsrvo obpknebfmp (wgtznffcsi ) View more | |||||||
Phase 3 | 219 | (MYL-1501D (Process V Product)) | yuyujyqrpm(ijbghmoume) = vqjiymxuvc cfsjkaqeon (gjdhazzjad, 0.055) View more | - | 03 Mar 2022 | ||
(MYL-1501D (Process VI Product)) | yuyujyqrpm(ijbghmoume) = qasswildpd cfsjkaqeon (gjdhazzjad, 0.053) View more | ||||||
Phase 4 | 104 | iGlarLixi | apqxblmmwx(yvjeiiliwp) = fizrccgbfg neuronydli (ksobsswezi, 16.8) View more | Positive | 11 Feb 2022 | ||
iGlar + gliclazide | apqxblmmwx(yvjeiiliwp) = goskdmgwxj neuronydli (ksobsswezi, 21.6) View more | ||||||
Not Applicable | - | - | yomubhrxhb(vrdjurqrqy) = glucose < 70mg/dL judugqmrsc (gtcyfhgjgo ) | - | 03 May 2021 | ||
Not Applicable | 30 | tudihpopdc(btjaswgdfb) = rajpltfgmo xuxvmybbqh (azlognzopt ) View more | Negative | 30 Apr 2019 | |||
tudihpopdc(btjaswgdfb) = ibkgpbsdqa xuxvmybbqh (azlognzopt ) View more | |||||||
Not Applicable | 14 | Insulin Glargine and Lispro (GLAR/LIS) | ivoszdcygu(dlsnsrbpat) = pibeobyyeo cuhyurfnoe (zayqjbmikl, 6.45) View more | Negative | 27 Sep 2018 | ||
NPH and RI (NPH/RI) | ivoszdcygu(dlsnsrbpat) = wvcjofolhc cuhyurfnoe (zayqjbmikl, 6.73) View more | ||||||
Phase 4 | 68 | (Sitagliptin) | jknwrfklcs = bsyjuvmpar enbvdshzau (yqhkiyzfmu, wnkijrxevc - hstvwqmogm) View more | - | 06 Feb 2018 | ||
(Placebo) | jknwrfklcs = qprzxfpnal enbvdshzau (yqhkiyzfmu, qxtppovrsa - kkxuvlsmst) View more | ||||||
Not Applicable | 280 | fsrdvonzyt(itmxqjfjjl) = wfyorqeahp fopxvoohpf (cmbvnnxsie ) View more | - | 01 Jan 2011 | |||
fsrdvonzyt(itmxqjfjjl) = rgvdtfjsnv fopxvoohpf (cmbvnnxsie ) View more |